Your session is about to expire
← Back to Search
Neuraceq™ PET Imaging for Concussion
Study Summary
This trial will study how well a PET scan using Neuraceq™ can detect changes in the brains of young athletes who had concussions at least 5 years ago.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
Is enrollment still available for this investigation?
"Based on information provided by clinicaltrials.gov, this study has concluded patient recruitment, with the first posting made on July 13th 2017 and the most recent update occurring on February 25th 2022. Though this trial is no longer actively recruiting patients, there are 76 other research projects currently enrolling volunteers."
Is enrollment for this trial open to individuals aged fifty and above?
"The minimal entry age for this medical trial is 18, while the upper limit of eligibility lies at 40 years."
Is participation in this medical study a viable option for me?
"This research study requires 15 individuals aged between 18 and 40 who have suffered a concussion, brain injury or mTBI. To be considered for the trial, prospective participants must meet the American Congress of Rehabilitative Medicine's definition of concussion-related impairments as well as having had at least one such incident within the year prior to enrollment in addition to demonstrating either subjective or objective evidence of cognitive impairment."
Who else is applying?
What state do they live in?
How old are they?
What site did they apply to?
What portion of applicants met pre-screening criteria?
Share this study with friends
Copy Link
Messenger